NVS
Novartis AG ADR
3월 12일 3:54 PM ET (한국 3/13 04:54)
$155.80
-5.79 ▼ -3.58%
☀️ 3월 12일 9:10 AM ET (한국 3/12 22:10)
$154.78
+0.58 ▲ +0.38%
| Index | - | P/E | 21.68 | EPS (ttm) | 7.19 | Insider Own | - | Shs Outstand | 1.91B | Perf Week | -5.66% |
| Market Cap | 297.29B | Forward P/E | 16.09 | EPS next Y | 10.02% | Insider Trans | - | Shs Float | 1.91B | Perf Month | -0.8% |
| Enterprise Value | 321.49B | PEG | 2.63 | EPS next Q | 2.11 | Inst Own | 7.08% | Short Float | 0.36% | Perf Quarter | 19.69% |
| Income | 14.04B | P/S | 5.43 | EPS this Y | -1.98% | Inst Trans | -0.14% | Short Ratio | 3.13 | Perf Half Y | 21.67% |
| Sales | 54.73B | P/B | 6.44 | EPS next 5Y | 6.11% | ROA | 12.63% | Short Interest | 6.85M | Perf YTD | 13.01% |
| Book/sh | 24.18 | P/C | 25.65 | EPS past 3/5Y | 31.4% 15.38% | ROE | 31.14% | 52W High | -8.6% ($170.46) | Perf Year | 39.92% |
| Cash/sh | 6.07 | P/FCF | 16.81 | Sales past 3/5Y | 9.03% 2.41% | ROIC | 18.54% | 52W Low | 59.44% ($97.71) | Perf 3Y | 104.1% |
| Dividend Est. | $4.4 (2.83%) | EV/EBITDA | 14.49 | EPS Y/Y TTM | 22.38% | Gross Margin | 75.02% | Volatility(W/M) | 2.11% 1.51% | Perf 5Y | 94.3% |
| Dividend TTM | 4.77 | EV/Sales | 5.87 | Sales Y/Y TTM | 8.87% | Oper. Margin | 31.16% | ATR (14) | 3.63 | Perf 10Y | 146.93% |
| Dividend Ex-Date | 2026/3/11 | Quick Ratio | 0.89 | EPS Q/Q | -10.56% | Profit Margin | 25.66% | RSI (14) | 42.88 | Recom | 2.59 |
| Dividend Gr. 3/5Y | 10.95% 8.31% | Current Ratio | 1.12 | Sales Q/Q | 2.11% | SMA20 | -4.79% ($163.64) | Beta | 0.5 | Target Price | $152.97 |
| Payout | 42.8% | Debt/Eq | 0.77 | Earnings | 2000000 | SMA50 | 1.74% ($153.14) | Rel Volume | 2.36 | Prev Close | $161.59 |
| Employees | 75267 | LT Debt/Eq | 0.64 | EPS/Sales Surpr. | 2.38% -2.69% | SMA200 | 18.21% ($131.8) | Avg Volume(3M) | 2.19M | Price | $155.8 |
| IPO | 1996/11/7 | Option/Short | Yes/Yes | Trades | 22950 | Volume | 5,153,643 | Change | -3.58% |
뉴스 로딩 중...